Table 4.
Cluster | Straina | MIC (μg/mL) | Antibiotic susceptibility | E-test MIC (μg/mL) | ||||
---|---|---|---|---|---|---|---|---|
OXA | RIF | TEI | OXA | RIF | TEI | |||
C1 | S15 | 1.5 | S | S | S | 1 | 0.064 | 2 |
S1560 | 16 | S | R | I | 0.5 | >256 | 16 | |
S16 | 1.5 | S | R | S | 1 | >256 | 4 | |
S1660 | 16 | S | R | R | 0.5 | >256 | 16 | |
S41 | 1 | S | S | S | 0.5 | 0.064 | 1 | |
S4160 | 16 | S | S | S | 0.5 | 0.064 | 8 | |
S28 | 1.5 | S | S | S | 0.25 | 0.064 | 4 | |
S2860 | 14 | S | S | I | 0.25 | 0.064 | 16 | |
C2 | S8 | 1.5 | S | S | S | 0.5 | 0.064 | 2 |
S860 | 16 | S | S | I | 0.5 | 0.064 | 16 | |
S9 | 1.5 | S | S | S | 0.25 | 0.064 | 2 | |
S960 | 12 | S | S | I | 0.25 | 0.064 | 16 | |
S32 | 1.5 | S | S | S | 0.125 | 0.064 | 2 | |
S3260 | 12 | S | S | I | 0.125 | 0.064 | 16 | |
C3 | S3 | 1.5 | R | R | S | >256 | >256 | 1 |
S360 | 10 | R | R | S | 32 | >256 | 8 | |
S34 | 0.5 | R | S | S | 32 | 0.064 | 0.5 | |
S3460 | 6 | R | S | S | 8 | 0.064 | 4 | |
S35 | 1.5 | S | S | S | 0.25 | 0.064 | 1 | |
S3560 | 12 | S | R | S | 0.5 | >256 | 8 | |
S37 | 1 | R | S | S | >256 | 1 | 0.5 | |
S3760 | 8 | R | R | S | 4 | 4 | 8 | |
C4 | S2 | 1.5 | S | S | S | 0.125 | 0.064 | 2 |
S260 | 3 | S | S | S | 0.25 | 0.064 | 2 | |
S5 | 1.5 | S | S | S | 0.125 | 0.064 | 1 | |
S560 | 4 | S | S | S | 0.125 | 0.064 | 2 | |
S11 | 1 | S | S | S | 0.5 | 0.064 | 0.064 | |
S1160 | 8 | S | S | S | 0.5 | 0.064 | 8 | |
C5 | S10 | 1 | S | S | S | 0.25 | 0.064 | 1 |
S1060 | 1 | S | S | S | 0.25 | 0.064 | 1 |
OXA, oxacillin; RIF, rifampicin; TEI, teicoplanin. S, susceptible; I, intermediate; R, resistant.
No subscript represents parental strains.
Subscript indicates strains treated by vancomycin for 60 days.